Isoplexis

Isoplexis company information, Employees & Contact Information

Explore related pages

Related company profiles:

Isoplexis is now part of Bruker Cellular Analysis

Company Details

Employees
48
Founded
-
Address
35 Ne Industrial Road, Branford,connecticut 06405,united States
Email
in****@****xis.com
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
Branford, Connecticut
Looking for a particular Isoplexis employee's phone or email?

Isoplexis Questions

News

IsoPlexis Reports Preliminary Full Year 2022 Revenue - Yahoo Finance

IsoPlexis Reports Preliminary Full Year 2022 Revenue Yahoo Finance

Accelerating decisions in immunotherapy with predictive single-cell response - Nature

Accelerating decisions in immunotherapy with predictive single-cell response Nature

IsoPlexis Announces Pricing of Initial Public Offering - PR Newswire

IsoPlexis Announces Pricing of Initial Public Offering PR Newswire

IsoPlexis’ Functional Proteomics Uncovers Predictive Biomarkers - Inside Precision Medicine

IsoPlexis’ Functional Proteomics Uncovers Predictive Biomarkers Inside Precision Medicine

Berkeley Lights to Acquire IsoPlexis, Creating a Premier Functional Cell Biology Company - GlobeNewswire

Berkeley Lights to Acquire IsoPlexis, Creating a Premier Functional Cell Biology Company GlobeNewswire

IsoSpark, IsoLight, and IsoSpark Duo: Accelerating the Next Big Breakthrough in Immune Medicine - Genetic Engineering and Biotechnology News

IsoSpark, IsoLight, and IsoSpark Duo: Accelerating the Next Big Breakthrough in Immune Medicine Genetic Engineering and Biotechnology News

Functional single-cell proteomics firm Isoplexis misses IPO target - drugdiscoverytrends.com

Functional single-cell proteomics firm Isoplexis misses IPO target drugdiscoverytrends.com

Isoplexis takes on cancer, one cell at a time - YaleNews

Isoplexis takes on cancer, one cell at a time YaleNews

IsoPlexis secures $135M to boost its single-cell protein analysis tech - Fierce Biotech

IsoPlexis secures $135M to boost its single-cell protein analysis tech Fierce Biotech

Profile: IsoPlexis Analyzes Thousands of Cells to Fight Cancer - IEEE Spectrum

Profile: IsoPlexis Analyzes Thousands of Cells to Fight Cancer IEEE Spectrum

IsoPlexis to Present First-of-Its-Kind Data on Simultaneous Single Cell TCR Profiling and Highly Multiplexed Functional Proteomics at AACR 2022 - Yahoo Finance

IsoPlexis to Present First-of-Its-Kind Data on Simultaneous Single Cell TCR Profiling and Highly Multiplexed Functional Proteomics at AACR 2022 Yahoo Finance

ISO IPO News - Proteomics platform IsoPlexis files for a $100 million IPO - renaissancecapital.com

ISO IPO News - Proteomics platform IsoPlexis files for a $100 million IPO renaissancecapital.com

Duomic: IsoPlexis Introduces Integrated Single-Cell Functional Multi-omic Biology Platform - BioSpace

Duomic: IsoPlexis Introduces Integrated Single-Cell Functional Multi-omic Biology Platform BioSpace

Predicting and Overcoming Resistance Using IsoPlexis' Single-Cell Intracellular Proteomic and Metabolomic Analysis Tools - the-scientist.com

Predicting and Overcoming Resistance Using IsoPlexis' Single-Cell Intracellular Proteomic and Metabolomic Analysis Tools the-scientist.com

IsoPlexis Nets $111M from IPO to Expand Platform, Product Offerings, Distribution Network - Genetic Engineering and Biotechnology News

IsoPlexis Nets $111M from IPO to Expand Platform, Product Offerings, Distribution Network Genetic Engineering and Biotechnology News

IsoPlexis Launches Personalized Lab System, the IsoSpark, to Continue Scaling to Many Labs Worldwide - PR Newswire

IsoPlexis Launches Personalized Lab System, the IsoSpark, to Continue Scaling to Many Labs Worldwide PR Newswire

BPI News: Bruker to Acquire PhenomeX, a Merger of Berkeley Lights and IsoPlexis - Genetic Engineering and Biotechnology News

BPI News: Bruker to Acquire PhenomeX, a Merger of Berkeley Lights and IsoPlexis Genetic Engineering and Biotechnology News

Berkeley Lights Reports Fourth Quarter and Full Year 2022 Financial Results - PR Newswire

Berkeley Lights Reports Fourth Quarter and Full Year 2022 Financial Results PR Newswire

Berkeley Lights Completes Acquisition of IsoPlexis Forming PhenomeX, the Functional Cell Biology Company - PR Newswire

Berkeley Lights Completes Acquisition of IsoPlexis Forming PhenomeX, the Functional Cell Biology Company PR Newswire

IsoPlexis, a company uncovering a ‘new layer’ of cell data, aims for $125M in market debut - TechCrunch

IsoPlexis, a company uncovering a ‘new layer’ of cell data, aims for $125M in market debut TechCrunch

IsoPlexis and Miltenyi Report on Synergistic CAR-T Cell Technologies - Genetic Engineering and Biotechnology News

IsoPlexis and Miltenyi Report on Synergistic CAR-T Cell Technologies Genetic Engineering and Biotechnology News

A Functional Cell Biology Company Is Formed - Genetic Engineering and Biotechnology News

A Functional Cell Biology Company Is Formed Genetic Engineering and Biotechnology News

Berkeley Lights Agrees to $57.8 Million Deal for IsoPlexis - Bloomberg

Berkeley Lights Agrees to $57.8 Million Deal for IsoPlexis Bloomberg

IsoPlexis Appoints Nachum “Homi” Shamir to its Board of Directors - citybiz

IsoPlexis Appoints Nachum “Homi” Shamir to its Board of Directors citybiz

Branford company developing cancer-fighting therapy seeks $100 million public stock offering - New Haven Register

Branford company developing cancer-fighting therapy seeks $100 million public stock offering New Haven Register

Searching for Superhero Cells: IsoPlexis leverages new tech to fight diseases - Hartford Business Journal

Searching for Superhero Cells: IsoPlexis leverages new tech to fight diseases Hartford Business Journal

IsoPlexis appoints new board member - Hartford Business Journal

IsoPlexis appoints new board member Hartford Business Journal

IsoPlexis Wins $1.8M NCI SBIR Grant toward Platform to Assess CAR-T Therapies - Inside Precision Medicine

IsoPlexis Wins $1.8M NCI SBIR Grant toward Platform to Assess CAR-T Therapies Inside Precision Medicine

IsoPlexis Appoints Richard Rew as Senior VP, General Counsel and Raj Khakhar as VP of Finance - citybiz

IsoPlexis Appoints Richard Rew as Senior VP, General Counsel and Raj Khakhar as VP of Finance citybiz

IsoPlexis’ New Software Designed for Better Insights on Single-Cell Immune Activation - Genetic Engineering and Biotechnology News

IsoPlexis’ New Software Designed for Better Insights on Single-Cell Immune Activation Genetic Engineering and Biotechnology News

IsoPlexis Launches Suite of New Products Enabling Multiple Automated Applications on the IsoLight - BioSpace

IsoPlexis Launches Suite of New Products Enabling Multiple Automated Applications on the IsoLight BioSpace

IsoPlexis (ISO) Stock Price, News & Analysis - MarketBeat

IsoPlexis (ISO) Stock Price, News & Analysis MarketBeat

Precipio partners with Israeli AI firm; Calif. drug maker taps IsoPlexis technology - Hartford Business Journal

Precipio partners with Israeli AI firm; Calif. drug maker taps IsoPlexis technology Hartford Business Journal

Top Isoplexis Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant